Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883)

Price and availability

274 732 ₸

Availability

Order now and get it on Wednesday March 03, 2021

Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Rabbit polyclonal to Carbonic Anhydrase 9/CA9
  • Suitable for: IHC-P, WB
  • Reacts with: Human
  • Isotype: IgG

You may also be interested in

Product image
Recombinant human SCF protein (Active) (ab269144)
Product image
Human CMPK2 knockout A549 cell lysate (ab258369)
Product image
Anti-Wnt7a antibody (ab217844)
Product image
Anti-GPD2 antibody [EPR14259] (ab188585)

Overview

  • Product name

    Anti-Carbonic Anhydrase 9/CA9 antibody
    See all Carbonic Anhydrase 9/CA9 primary antibodies
  • Description

    Rabbit polyclonal to Carbonic Anhydrase 9/CA9
  • Host species

    Rabbit
  • Tested Applications & Species

    Application Species
    IHC-P
    Human
    WB
    Human
    See all applications and species data
  • Immunogen

    Synthetic peptide corresponding to Human Carbonic Anhydrase 9/CA9 aa 400 to the C-terminus (C terminal) conjugated to keyhole limpet haemocyanin.
    (Peptide available as ab156179)

  • Positive control

    • This antibody gave a positive signal in both A549 and Ramos whole cell lysates within WB as well as in Human kidney carcinoma formalin fixed paraffin embedded tissue section within IHC.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage buffer

    pH: 7.40
    Preservative: 0.02% Sodium azide
    Constituent: PBS

    Batches of this product that have a concentration
  • Concentration information loading...
  • Purity

    Immunogen affinity purified
  • Clonality

    Polyclonal
  • Isotype

    IgG
  • Research areas

    • Cardiovascular
    • Hypoxia
    • Associated Proteins
    • Signal Transduction
    • Metabolism
    • Vitamins / Minerals
    • Cancer
    • Cancer Metabolism
    • Response to hypoxia
    • Metabolism
    • Pathways and Processes
    • Cofactors, Vitamins / minerals
    • Vitamins / minerals
    • Metabolism
    • Pathways and Processes
    • Metabolism processes
    • Hypoxia

Associated products

  • Compatible Secondaries

    • Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077)
    • Goat Anti-Rabbit IgG H&L (HRP) (ab205718)
  • Isotype control

    • Rabbit IgG, polyclonal - Isotype Control (ChIP Grade) (ab171870)

Applications

The Abpromise guarantee

Our Abpromise guarantee covers the use of ab128883 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Guaranteed

Tested applications are guaranteed to work and covered by our Abpromise guarantee.

Predicted

Predicted to work for this combination of applications and species but not guaranteed.

Incompatible

Does not work for this combination of applications and species.

Application Species
IHC-P
Human
WB
Human
All applications
Chimpanzee
Macaque monkey
Orangutan
Application Abreviews Notes
IHC-P
Use a concentration of 5 µg/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
WB (1)
Use a concentration of 1 µg/ml. Detects a band of approximately 55 kDa (predicted molecular weight: 49 kDa).
Notes
IHC-P
Use a concentration of 5 µg/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
WB
Use a concentration of 1 µg/ml. Detects a band of approximately 55 kDa (predicted molecular weight: 49 kDa).

Target

  • Function

    Reversible hydration of carbon dioxide. Participates in pH regulation. May be involved in the control of cell proliferation and transformation. Appears to be a novel specific biomarker for a cervical neoplasia.
  • Tissue specificity

    Expressed primarily in carcinoma cells lines. Expression is restricted to very few normal tissues and the most abundant expression is found in the epithelial cells of gastric mucosa.
  • Sequence similarities

    Belongs to the alpha-carbonic anhydrase family.
    Contains 1 alpha-carbonic anhydrase domain.
  • Post-translational
    modifications

    Asn-346 bears high-mannose type glycan structures.
  • Cellular localization

    Nucleus. Nucleus, nucleolus. Cell membrane. Cell projection, microvillus membrane. Found on the surface microvilli and in the nucleus, particularly in nucleolus.
  • Target information above from: UniProt accession Q16790 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links

    • Entrez Gene: 768 Human
    • Omim: 603179 Human
    • SwissProt: Q16790 Human
    • Unigene: 63287 Human
    • Alternative names

      • CA-IX antibody
      • CA9 antibody
      • CAH9_HUMAN antibody
      • CAIX antibody
      • Carbonate dehydratase IX antibody
      • Carbonic anhydrase 9 antibody
      • Carbonic anhydrase IX antibody
      • Carbonic dehydratase antibody
      • G250 antibody
      • Membrane antigen MN antibody
      • MN antibody
      • P54/58N antibody
      • pMW1 antibody
      • RCC associated protein G250 antibody
      • RCC-associated antigen G250 antibody
      • Renal cell carcinoma-associated antigen G250 antibody
      see all

    Images

    • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883)
      Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883)

      IHC image of Carbonic Anhydrase 9/CA9 staining in Human kidney carcinoma formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab128882, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

      For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

    • Western blot - Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883)
      Western blot - Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883)
      All lanes : Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883) at 1 µg/ml

      Lane 1 : Ramos (Human Burkitt's lymphoma cell line) Whole Cell Lysate
      Lane 2 : A549 (Human lung adenocarcinoma epithelial cell line) Whole Cell Lysate

      Lysates/proteins at 10 µg per lane.

      Secondary
      All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/10000 dilution

      Developed using the ECL technique.

      Performed under reducing conditions.

      Predicted band size: 49 kDa
      Observed band size: 55 kDa
      why is the actual band size different from the predicted?
      Additional bands at: 36 kDa, 50 kDa, 85 kDa. We are unsure as to the identity of these extra bands.


      Exposure time: 12 minutes


      Carbonic Anhydrase IX contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted. This blot was produced using a 10% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 5% Bovine Serum Albumin before being incubated with ab128883 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution.

    Protocols

    • Western blot protocols
    • Immunohistochemistry protocols

    Click here to view the general protocols

    Datasheets and documents

    • Datasheet
  • References (2)

    Publishing research using ab128883? Please let us know so that we can cite the reference in this datasheet.

    ab128883 has been referenced in 2 publications.

    • Frohwitter G  et al. Site-specific gene expression patterns in oral cancer. Head Face Med 13:6 (2017). IHC-P ; Human . PubMed: 28486965
    • Frohwitter G  et al. Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways. Oncol Lett 12:107-113 (2016). PubMed: 27347109

    Images

    • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883)
      Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883)

      IHC image of Carbonic Anhydrase 9/CA9 staining in Human kidney carcinoma formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab128882, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

      For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

    • Western blot - Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883)
      Western blot - Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883)
      All lanes : Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883) at 1 µg/ml

      Lane 1 : Ramos (Human Burkitt's lymphoma cell line) Whole Cell Lysate
      Lane 2 : A549 (Human lung adenocarcinoma epithelial cell line) Whole Cell Lysate

      Lysates/proteins at 10 µg per lane.

      Secondary
      All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/10000 dilution

      Developed using the ECL technique.

      Performed under reducing conditions.

      Predicted band size: 49 kDa
      Observed band size: 55 kDa
      why is the actual band size different from the predicted?
      Additional bands at: 36 kDa, 50 kDa, 85 kDa. We are unsure as to the identity of these extra bands.


      Exposure time: 12 minutes


      Carbonic Anhydrase IX contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted. This blot was produced using a 10% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 5% Bovine Serum Albumin before being incubated with ab128883 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Alternative products to Anti-Carbonic Anhydrase 9/CA9 antibody (ab128883)

    •  
    • Product image

      Anti-Carbonic Anhydrase 9/CA9 antibody (ab10471)

      Applications: ICC/IF, WB

    •  
    • Product image

      Anti-Carbonic Anhydrase 9/CA9 antibody [2D3] (ab107257)

      Applications: Flow Cyt, IHC-P, WB

    •  
    • Product image

      Alexa Fluor® 488 Anti-Carbonic Anhydrase 9/CA9 antibody [EPR4151(2)] (ab225075)

      Applications: IHC-P

    •  
    • Product image

      Anti-Carbonic Anhydrase 9/CA9 antibody [SP106] (ab105226)

      Applications: Flow Cyt, IHC-P

    •  
    • Product image

      Anti-Carbonic Anhydrase 9/CA9 antibody (ab184006)

      Applications: ICC/IF, IHC-P, WB

    •  
    • Product image

      Anti-Carbonic Anhydrase 9/CA9 antibody [10F7A8] - N-terminal (ab181464)

      Applications: Flow Cyt, WB

    •  
    • Product image

      Anti-Carbonic Anhydrase 9/CA9 antibody (ab15086)

      Applications: WB

    •  
    • Product image

      Anti-Carbonic Anhydrase 9/CA9 antibody [SP106] - BSA and Azide free (ab243910)

      Applications: Flow Cyt, IHC-P

    •  
    • Product image

      Anti-Carbonic Anhydrase 9/CA9 antibody [EPR4151(2)] - BSA and Azide free (ab180539)

      Applications: IHC-P, WB

    Clear all

    Recently viewed products

    •  
    • Product image

      Anti-BAP31 antibody [7A3BB6] (ab112993)

    •  
    • Product image

      Anti-ELMO1 antibody [EPR12919] (ab174298)

    •  
    • Product image

      Anti-RPA32/RPA2 (phospho T21) antibody [EPR2846(2)] (ab109394)

    •  
    • Product image

      Anti-Fibulin-4 antibody [EPR684(2)] (ab125073)

    •  
    • Product image

      Anti-BLAP75 antibody [EPR12157(B)] (ab172625)

    •  
    • Product image

      Anti-Retinoic Acid Receptor alpha antibody [763] (ab254098)

    Get resources and offers direct to your inbox Sign up
    © 2021 Astana Biomed Group LLP. All rights reserved.